To provide a novel combination therapy which exhibits remarkable anti-tumor effect.The invention provides an anti-tumor agent comprising a combination drug containing tegafur, gimeracil and oteracil potassium, oxaliplatin, and TSU-68 or a salt thereof, in combination.